Celularity Regains Compliance With Nasdaq Financial Reporting Requirement
Bitget2026/10/22 12:08- Celularity regained compliance with Nasdaq's periodic reporting requirement on Oct. 22, 2026, closing the last of three previously disclosed deficiency matters.
- The determination followed its Oct. 20, 2026, Form 10-Q filing for the quarter ended June 30, 2026.
- Nasdaq previously closed minimum bid price and minimum market value of listed securities deficiencies on Sept. 11, 2026.
- Management has begun overhauling the finance organization to address recurring reporting delays.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
KKR Real Estate Select Trust Presents Real Estate Investment Strategy
Euro edges back to 1.10 from a 19-month low as the Dollar eases
U.S. Treasury’s Long-Term Bond Repo Volume Falls Far Short of Expectations, Actual Amount Less Than 20% of Original Target
The long-term Treasury bond repurchase operation conducted by the U.S. Department of the Treasury on Tuesday was significantly below expectations, with an actual repurchase amount of only 118 million USD, less than 20% of the original 600 million USD target.

CFN Enterprises Delays Quarterly Report as Financial Statements Remain Incomplete